Prostaglandin DP2 receptor

From WikiMD's WELLNESSPEDIA

Prostaglandin D2 receptor 2 (also known as DP2, CRTH2, or GPR44) is a protein that in humans is encoded by the PTGDR2 gene. DP2 is a member of the G protein-coupled receptor family and is a receptor for prostaglandin D2 (PGD2).

Function[edit]

The DP2 receptor is one of two G protein-coupled receptors that have been identified as receptors for prostaglandin D2. The other receptor is known as DP1. DP2 is expressed on the surface of various types of white blood cells, including eosinophils, basophils, and T helper cells.

When PGD2 binds to the DP2 receptor, it triggers a cascade of intracellular events including an increase in the intracellular concentration of calcium ions and the activation of the protein kinase pathway. This leads to a response in the cell, such as chemotaxis, the movement of a cell in response to a chemical stimulus.

Clinical significance[edit]

The DP2 receptor has been implicated in a variety of diseases, including asthma, allergic rhinitis, and atopic dermatitis. In these conditions, the activation of the DP2 receptor by PGD2 leads to an inflammatory response, which contributes to the symptoms of the disease.

Several drugs that block the DP2 receptor have been developed for the treatment of these conditions. These drugs, known as DP2 antagonists, prevent PGD2 from binding to the DP2 receptor, thereby reducing the inflammatory response.

See also[edit]

References[edit]


External links[edit]





Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.